Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Primary cutaneous lymphomas: a review with current treatment options
Christiane Querfeld, Joan Guitart, Timothy M. Kuzel, et al.
Blood Reviews (2003) Vol. 17, Iss. 3, pp. 131-142
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

HDAC inhibitor-based therapies and haematological malignancy
Lindsay Stimson, Victoria Wood, Omar Khan, et al.
Annals of Oncology (2009) Vol. 20, Iss. 8, pp. 1293-1302
Open Access | Times Cited: 130
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center
Christiane Querfeld, Neha Mehta, Steven T. Rosen, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2009) Vol. 50, Iss. 12, pp. 1969-1976
Closed Access | Times Cited: 102
The Selective Protein Kinase C β Inhibitor Enzastaurin Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines through the AKT Pathway
Christiane Querfeld, Mujahid A. Rizvi, Timothy M. Kuzel, et al.
Journal of Investigative Dermatology (2006) Vol. 126, Iss. 7, pp. 1641-1647
Open Access | Times Cited: 90
Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas
Omar Khan, Nicholas B. La Thangue
Nature Clinical Practice Oncology (2008) Vol. 5, Iss. 12, pp. 714-726
Closed Access | Times Cited: 86
Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
Christiane Querfeld, Timothy M. Kuzel, Youn H. Kim, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2011) Vol. 52, Iss. 8, pp. 1474-1480
Closed Access | Times Cited: 34
Comparison of selective retinoic acid receptor– and retinoic X receptor–mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma
Christiane Querfeld, Steven T. Rosen, Joan Guitart, et al.
Journal of the American Academy of Dermatology (2004) Vol. 51, Iss. 1, pp. 25-32
Closed Access | Times Cited: 50
Primary Cutaneous T-Cell Lymphomas
Steven T. Rosen, Christiane Querfeld
Hematology (2006) Vol. 2006, Iss. 1, pp. 323-330
Open Access | Times Cited: 47
Bexarotene in the treatment of cutaneous T-cell lymphoma
Christiane Querfeld, Lakshmi V Nagelli, Steven T. Rosen, et al.
Expert Opinion on Pharmacotherapy (2006) Vol. 7, Iss. 7, pp. 907-915
Closed Access | Times Cited: 46
Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma
Fani Karagianni, Christina Piperi, Berta Casar, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1070-1070
Open Access | Times Cited: 12
Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions
Belén Rubio-González, Jasmine Zain, Steven T. Rosen, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 1, pp. 16-36
Open Access | Times Cited: 18
Cutaneous T‐cell lymphoma cells are sensitive to rapamycin
Melanie Kremer, Katja Sliva, Claus‐Detlev Klemke, et al.
Experimental Dermatology (2010) Vol. 19, Iss. 9, pp. 800-805
Closed Access | Times Cited: 22
Primary Cutaneous B-Cell Lymphoma: Role of Surgery
Sam Parbhakar, Arianna Dal Cin
Canadian Journal of Plastic Surgery (2011) Vol. 19, Iss. 2, pp. 12-14
Closed Access | Times Cited: 18
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma
Małgorzata Sokołowska–Wojdyło, Aleksandra G. Florek, Jan Maciej Zaucha, et al.
American Journal of Therapeutics (2014) Vol. 23, Iss. 3, pp. e749-e756
Closed Access | Times Cited: 15
Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome
Christiane Querfeld, Steven T. Rosen, Joan Guitart, et al.
Journal of the American Academy of Dermatology (2006) Vol. 56, Iss. 4, pp. 580-583
Closed Access | Times Cited: 22
Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells
Ingerlisa W. Mattoch, Regan Fulton, Hyun Soo Kim, et al.
American Journal of Clinical Pathology (2009) Vol. 131, Iss. 6, pp. 810-819
Closed Access | Times Cited: 16
Identification of p38β as a Therapeutic Target for the Treatment of Sézary Syndrome
Meghan Bliss‐Moreau, Cristian Coarfa, Preethi H. Gunaratne, et al.
Journal of Investigative Dermatology (2014) Vol. 135, Iss. 2, pp. 599-608
Open Access | Times Cited: 13
Primary cutaneous lymphoma in southern Brazil: a 12‐year single‐center experience
Lisia Martins Nudelmann, Renan Rangel Bonamigo
International Journal of Dermatology (2015) Vol. 54, Iss. 12
Closed Access | Times Cited: 11
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type, with the Clinical Picture of Chronic Venous Ulceration
Anke Süß, Simon Jc, Michael Sticherling
Acta Dermato Venereologica (2007) Vol. 87, Iss. 2, pp. 169-170
Open Access | Times Cited: 14
Primary cutaneous marginal zone B-cell lymphoma in a patient with chronic lymphocytic leukaemia
Ewa Robak, Dorota Jesionek‐Kupnicka, Tadeusz Robak, et al.
British Journal of Dermatology (2007) Vol. 157, Iss. 3, pp. 591-595
Closed Access | Times Cited: 13
Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
M Sitki Copur, Anita Deshpande, Kris Mleczko, et al.
PubMed (2005) Vol. 46, Iss. 3, pp. 458-62
Closed Access | Times Cited: 15
Transformation of Sézary Syndrome Into CD30+ Anaplastic Large T-Cell Lymphoma After Alemtuzumab Therapy With Evidence of Clonal Unity
Mariela J. Nevet, Tsila Zuckerman, Dvora Sahar, et al.
American Journal of Dermatopathology (2014) Vol. 37, Iss. 1, pp. 73-77
Closed Access | Times Cited: 6
Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphoma
Jadesola T. Olayinka, Akanksha Nagarkar, Diana Junyue, et al.
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 2
Cancer Therapies: Current Scenario, Management, and Safety Aspects
Santosh Shivaswamy, Manasa D. Rajagopalan, Bangalore Acharlu Pallavi, et al.
Springer eBooks (2017), pp. 1-25
Closed Access | Times Cited: 5
Primary cutaneous B-cell lymphoma: Role of surgery
Sam Parbhakar, Arianna Dal Cin
Plastic Surgery (2011) Vol. 19, Iss. 02
Open Access | Times Cited: 5
Primary cutaneous diffuse large B-cell lymphoma, leg type, with expression of both vascular endothelial growth factor and its receptors
Shoko Nakayama, Taiji Yokote, Kichinosuke Kobayashi, et al.
Leukemia Research (2009) Vol. 33, Iss. 11, pp. e181-e183
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top